Scientific and ethical concerns in clinical trials in Alzheimer's patients: the bridging study N. R. CutlerJ. J. Sramek Special Article Pages: 421 - 428
Raised plasma levels of atrial natriuretic factor in cardiac allograft recipients: evidence of increased cardiac secretion and decreased renal clearance C. C. LangT. MorelandA. D. Struthers Pharmacodynamics Pages: 429 - 434
Effects of ACE inhibition on endurance exercise haemodynamics in trained subjects with mild hypertension P. PalatiniS. BongioviG. Raule Pharmacodynamics Pages: 435 - 439
Chronopharmacology of enalapril in hypertensive patients K. SunagaA. FujimuraA. Ebihara Pharmacodynamics Pages: 441 - 445
The cognitive and psychomotor effects of opioid analgesics W. M. O'NeillG. W. HanksK. Wesnes Pharmacodynamics Pages: 447 - 453
The cognitive and psychomotor effects of opioid analgesics G. W. HanksW. M. O'NeillK. Wesnes Pharmacodynamics Pages: 455 - 460
Comparative efficacy of hamamelis distillate and hydrocortisone cream in atopic eczema H. C. KortingM. Schäfer-KortingP. Laux Clinical Trials Pages: 461 - 465
Pharmacological effects of concomitant administration of β-adrenoceptor blocker and agonist in normal subjects: characterization by heart rate response to exercise M. KaritaH. SatoM. Inoue Pharmacodynamics Pages: 467 - 471
Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler D. DonnellS. WardJ. McEwen Pharmacodynamics Pages: 473 - 477
Variability of thiopental clearance in routine critical care patients H. RussoJ. BrèsB. Roquefeuil Pharmacokinetics and Disposition Pages: 479 - 487
Serum kinetics, bioavailability and bone scanning of 99mTc-labelled sodium olpadronate in patients with different rates of bone turnover O. J. DegrossiM. OrtizA. Pérez Lloret Pharmacokinetics and Disposition Pages: 489 - 494
Erythrocyte fraction affects red blood cell thiopurine methyltransferase activity B. KlemetsdalR. LysaaB. Straume Pharmacokinetics and Disposition Pages: 495 - 499
Lack of relationship between quinidine pharmacokinetics and the sparteine oxidation polymorphism F. NielsenJ. U. RosholmK. Brøsen Pharmacokinetics and Disposition Pages: 501 - 504
Comparison of the bioavailability of dexibuprofen administered alone or as part of racemic ibuprofen B. GabardG. NirnbergerJ. M. Mayer Pharmacokinetics and Disposition Pages: 505 - 511
Anticholinergic antiparkinsonian therapy in outpatients treated with neuroleptic drugs: a prescription survey S. Spila-AlegianiF. Menniti-IppolitoG. Diana Pharmacoepidemiology and Prescription Pages: 513 - 517
The pharmacokinetics of granisetron, a 5-HT3 antagonist in healthy young and elderly volunteers A. AllenC. C. DavieR. W. Jones Letter to the Editors Pages: 519 - 520
